Oramed Pharmaceuticals
ORMP
#8876
Rank
C$0.12 B
Marketcap
$3.04
Share price
-2.69%
Change (1 day)
8.05%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): C$33.97 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of C$9.97 Million, an increase over its 2022 earnings that were of -C$51.31 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$33.97 M240.48%
2023 C$9.97 M-119.45%
2022 -C$51.31 Million39.17%
2021 -C$36.87 Million73.93%
2020 -C$21.2 Million18.53%
2019 -C$17.89 Million-16.62%
2018 -C$21.45 Million38.32%
2017 -C$15.51 Million12.51%
2016 -C$13.78 Million25.01%
2015 -C$11.03 Million18.18%
2014 -C$9.33 Million39.72%
2013 -C$6.68 Million46.4%
2012 -C$4.57 Million128.32%
2011 -C$2 Million-51.47%
2010 -C$4.12 Million35.21%
2009 -C$3.05 Million
2007 -C$4.79 Million607.04%
2006 -C$0.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.73 Billion-2,157.69%๐Ÿ‡บ๐Ÿ‡ธ USA
C$23.60 B 66,581.97%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
C$10.37 B 29,210.12%๐Ÿ‡ซ๐Ÿ‡ท France
-C$0.72 Million-102.01%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-C$0.29 Billion-899.66%๐Ÿ‡บ๐Ÿ‡ธ USA